DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Firms / Vida Ventures Advisors
Vida Ventures Advisors
Institutional venture firmBoston, MAvidaventures.comSEC venture capital fund adviserone firm, 3 filing advisers
This firm files as 3 advisers on vidaventures.com: Vida Ventures Management, VV Manager LLC. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
venture manager, reported GAV $640M across 4 vehicles
Importance
27
moderate
Active deployment
4
low
Emerging
0
low
Completeness
69
high
Freshness
100
high
Research priority
5
low
Identity and regulatory footprint
- Headquarters
- Los Angeles, CAadviserinfo.sec.gov
- Office address
- 10100 SANTA MONICA BLVD, FLOOR 15, Los Angeles, CA, 90067adviserinfo.sec.gov
- Business phone
- 818-800-5840adviserinfo.sec.gov
- Website
- https://vidaventures.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 19, 2026
- Private funds reported
- 4 (4 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $469Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Bellco Capital LLC (Voting Member), C; Wildcat Capital Management, LLC (Voting Member), C
- business email
- info@vidaventures.comvidaventures.compublished by the subject
- business email
- investors@vidaventures.comvidaventures.compublished by the subject
- business email
- fellowship@vidaventures.comvidaventures.compublished by the subject
- business phone
- 415-378-9984adviserinfo.sec.govpublished by the subject
- business phone
- 818-800-5840adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
- Sectors
- biotech, media
- Stages
- series a, series b
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation
series b 100%
Stage at first entry
series b 100%
Sectors
Other Health Care 100%
lead rate 0%follow-on rate 0%new logos, 12 months 1
Funds and vehicles
4 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Vida Ventures II, LLC | Fund | 2019 form d first sale | Mature | $471M Apr 26, 2024 | 123 | $537M of $600M | Jul 15, 2019 |
| VV Atreus Special Fund LLC | Fund | 2019 form d first sale | Mature | $43.1M Apr 26, 2024 | 52 | $60.0M of $60.0M | Apr 22, 2019 |
| Vida Ventures Ii-A, LLC | Feeder or parallel | 2019 form d first sale | Mature | $13.3M Apr 26, 2024 | 10 | $16.0M of $600M | Jul 16, 2019 |
| Vida Ventures, LLC | Fund | 2017 form d first sale | Harvest | $112M Apr 26, 2024 | 60 | $255M of $255M | Dec 6, 2017 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
5 current, 0 departed
Arie Belldegrun
Managing partnerManaging Member · since Jan 1, 2004
Leonard a Potter
Managing partnerManaging Member / President · since Mar 1, 2012
Rebecka Belldegrun
Managing partnerManaging Member · since Jan 1, 2004
Fred Cohen
PartnerManagement Committee Member / Voting Member · since Apr 1, 2019
Jean-Philippe Kouakou-Zebouah
Platform and operationsChief Financial Officer/Chief Operating Officer · since Oct 1, 2019
Investments on record
1 edges, 1 companies, 0 partner-attributed
| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| Protego Biopharma, Inc. | Series B · Series B | participant | unknown | $130M | unknown | Dec 1, 2025 | Fact Press release wires (Business Wire, PR Newswire, GlobeNewswire public RSS) |
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
13 relationships from shared deals, counted for the whole firm
RA Capital Management, LP 2 shared · recurringVivo Capital, LLC 1 shared · one timeCanaan Partners 1 shared · one timeArch Venture Partners 1 shared · one timeOmega Fund Management, LLC 1 shared · one timeSofinnova Investments, Inc. 1 shared · one timeYK Bioventures 1 shared · one timeMPM Bioimpact 1 shared · one timeLightspeed Venture Partners 1 shared · one timeDroia Ventures 1 shared · one timeForbion 1 shared · one time · they led 1Novartis Venture Fund 1 shared · one time · they led 1Chris Weyrer 1 shared · one time
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
5 dated events
- Dec 24, 2019Vida Ventures Advisors, LLC first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Dec 24, 2019VV Atreus Special Fund LLC first reported on Form ADV by Vida Ventures Advisors, LLC (Venture Capital Fund), GAV $60,185,243Fund first reported on Form ADVFundsFactVV Atreus Special Fund LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Dec 24, 2019Vida Ventures Ii-A, LLC first reported on Form ADV by Vida Ventures Advisors, LLC (Venture Capital Fund), GAV $15,899,728Fund first reported on Form ADVFundsFactVida Ventures Ii-A, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Dec 24, 2019Vida Ventures II, LLC first reported on Form ADV by Vida Ventures Advisors, LLC (Venture Capital Fund), GAV $580,580,538Fund first reported on Form ADVFundsFactVida Ventures II, LLCSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Oct 1, 2019Jean-Philippe Kouakou-Zebouah joined Schedule A of Vida Ventures Advisors, LLC as Chief Financial Officer/Chief Operating Officer
Classification history
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $640M across 4 vehicles
Evidence
44 observations from 3 sources